Biosynex Statistics

Total Valuation

Biosynex has a market cap or net worth of EUR 30.35 million. The enterprise value is 82.60 million.

Market Cap	30.35M
Enterprise Value	82.60M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Biosynex has 10.76 million shares outstanding. The number of shares has increased by 9.49% in one year.

Current Share Class	n/a
Shares Outstanding	10.76M
Shares Change (YoY)	+9.49%
Shares Change (QoQ)	-6.05%
Owned by Insiders (%)	8.76%
Owned by Institutions (%)	n/a
Float	4.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.30
PB Ratio	0.29
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.15
EV / Sales	0.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.02

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.61.

Current Ratio	0.84
Quick Ratio	0.30
Debt / Equity	0.61
Debt / EBITDA	n/a
Debt / FCF	-3.07
Interest Coverage	-9.89

Financial Efficiency

Return on equity (ROE) is -31.52% and return on invested capital (ROIC) is -9.05%.

Return on Equity (ROE)	-31.52%
Return on Assets (ROA)	-7.13%
Return on Capital (ROIC)	-9.05%
Revenue Per Employee	202,070
Profits Per Employee	-74,715
Employee Count	569
Asset Turnover	0.43
Inventory Turnover	1.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-62.85%
50-Day Moving Average	3.68
200-Day Moving Average	4.30
Relative Strength Index (RSI)	33.31
Average Volume (20 Days)	8,425

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biosynex had revenue of EUR 104.07 million and -38.48 million in losses. Loss per share was -3.47.

Revenue	104.07M
Gross Profit	55.06M
Operating Income	-27.43M
Pretax Income	-40.61M
Net Income	-38.48M
EBITDA	-20.24M
EBIT	-27.43M
Loss Per Share	-3.47

Full Income Statement

Balance Sheet

The company has 10.74 million in cash and 63.03 million in debt, giving a net cash position of -52.29 million or -4.86 per share.

Cash & Cash Equivalents	10.74M
Total Debt	63.03M
Net Cash	-52.29M
Net Cash Per Share	-4.86
Equity (Book Value)	103.21M
Book Value Per Share	9.59
Working Capital	-13.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.92 million and capital expenditures -9.64 million, giving a free cash flow of -20.56 million.

Operating Cash Flow	-10.92M
Capital Expenditures	-9.64M
Free Cash Flow	-20.56M
FCF Per Share	-1.91

Full Cash Flow Statement

Margins

Gross margin is 52.91%, with operating and profit margins of -26.36% and -36.97%.

Gross Margin	52.91%
Operating Margin	-26.36%
Pretax Margin	-39.02%
Profit Margin	-36.97%
EBITDA Margin	-19.45%
EBIT Margin	-26.36%
FCF Margin	-19.76%

Dividends & Yields

Biosynex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.49%
Shareholder Yield	-9.49%
Earnings Yield	-123.19%
FCF Yield	-67.77%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biosynex has an Altman Z-Score of 1.08. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.08
Piotroski F-Score	n/a